GLP-1 & Metabolic

Retatrutide

Triple agonist (GLP-1 / GIP / glucagon) in Phase 3 metabolic research.

Semaglutide

GLP-1 analogue widely studied for weight and glycemic research.

Tirzepatide

Dual GLP-1 / GIP agonist used in metabolic research.

Liraglutide

Daily GLP-1 analogue, predecessor to semaglutide.

CagriSema

Cagrilintide + semaglutide combination under study.

Cagrilintide

Long-acting amylin analogue paired with GLP-1 agents.

Mazdutide

Dual GLP-1 / glucagon receptor agonist.

Survodutide

GLP-1 / glucagon dual agonist in clinical study.

Orforglipron

Oral non-peptide GLP-1 receptor agonist.

GLP2

GLP-2 analogue studied for intestinal repair.

GLP3

Experimental GLP-3 sequence.

Retatrutide Triblend

Blended research preparation of retatrutide.

Adipotide (FTPP)

Pro-apoptotic peptide studied for adipose tissue.

AOD9604

Modified hGH fragment investigated for fat metabolism.

hGH Fragment 176-191

C-terminal fragment of human growth hormone.

Pemvidutide

Dual GLP-1 / glucagon agonist in metabolic research.

VK2735

Dual GLP-1 / GIP agonist under investigation.

MariTide (AMG-133)

GLP-1 agonist / GIPR antagonist conjugate.

Danuglipron

Oral small-molecule GLP-1 receptor agonist.

Amycretin

GLP-1 / amylin dual agonist under study.

Cotadutide

GLP-1 / glucagon dual agonist.

Efinopegdutide

GLP-1 / glucagon dual agonist in metabolic research.

Lotiglipron

Oral non-peptide GLP-1 receptor agonist.

Tesofensine

Monoamine reuptake inhibitor studied for weight research.